 |
|
|
|
|
Nonmelanoma Skin Cancer Ups Risk for Other Cancers
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 In research led by Jennifer Christian, from the VA Medical Center and Brown University in Providence, R.I., researchers found that patients taking ACE inhibitors or ARBs had a 39 percent lower risk of developing basal cell skin cancer and a 33 percent lower risk of developing squamous cell skin cancer.
Why these drugs lower the risk of skin cancer isn't known, the researchers said.
More information
Text Continues Below
For more on skin cancer, visit the American Cancer Society.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/26/2008
|
|
SOURCES: Anthony Alberg, Ph.D., Medical University of South Carolina, Charleston; Robin Ashinoff, M.D., dermatologist and clinical associate professor, dermatology, New York University Medical Center, New York City; Martin Weinstock, M.D., Ph.D., chairman, skin cancer advisory committee, American Cancer Society; Aug. 26, 2008, online edition, Journal of the National Cancer Institute
|
.gif)
